14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.92 $1.42 Tuesday, 23rd Apr 2024 BLUE stock ended at $0.97. This is 1.78% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 10.09% from a day low at $0.95 to a day high of $1.05.
90 days $0.88 $1.92
52 weeks $0.88 $5.53

Historical bluebird bio prices

Date Open High Low Close Volume
Feb 09, 2024 $1.05 $1.08 $1.02 $1.03 4 823 474
Feb 08, 2024 $0.94 $1.08 $0.93 $1.05 7 872 809
Feb 07, 2024 $0.94 $0.96 $0.90 $0.94 12 152 321
Feb 06, 2024 $0.93 $0.98 $0.88 $0.94 10 545 039
Feb 05, 2024 $0.95 $0.97 $0.88 $0.91 11 371 603
Feb 02, 2024 $1.00 $1.01 $0.92 $0.96 10 275 380
Feb 01, 2024 $1.03 $1.03 $0.97 $1.00 10 531 164
Jan 31, 2024 $1.06 $1.07 $1.01 $1.02 8 985 028
Jan 30, 2024 $1.14 $1.14 $1.06 $1.06 5 390 498
Jan 29, 2024 $1.06 $1.15 $1.04 $1.13 6 714 967
Jan 26, 2024 $1.11 $1.15 $1.06 $1.06 7 911 789
Jan 25, 2024 $1.10 $1.15 $1.03 $1.12 7 792 899
Jan 24, 2024 $1.16 $1.17 $1.06 $1.07 12 919 937
Jan 23, 2024 $1.30 $1.30 $1.16 $1.17 10 918 662
Jan 22, 2024 $1.27 $1.33 $1.25 $1.27 6 119 286
Jan 19, 2024 $1.38 $1.38 $1.24 $1.27 12 406 936
Jan 18, 2024 $1.41 $1.47 $1.38 $1.39 7 444 359
Jan 17, 2024 $1.42 $1.43 $1.38 $1.41 7 473 505
Jan 16, 2024 $1.49 $1.51 $1.41 $1.43 7 777 419
Jan 12, 2024 $1.37 $1.51 $1.37 $1.50 11 549 335
Jan 11, 2024 $1.39 $1.40 $1.34 $1.38 8 700 505
Jan 10, 2024 $1.39 $1.40 $1.30 $1.38 12 559 257
Jan 09, 2024 $1.43 $1.44 $1.35 $1.37 8 518 416
Jan 08, 2024 $1.43 $1.49 $1.38 $1.47 10 830 404
Jan 05, 2024 $1.45 $1.49 $1.39 $1.42 9 583 446
Click to get the best stock tips daily for free!

About bluebird bio

bluebird bio bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clini... BLUE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT